UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                          Date of Report: June 6, 2006

                              Liska Biometry, Inc.
             (Exact name of registrant as specified in its chapter)

<TABLE>
<CAPTION>
<S>                                   <C>                                <C>
         Florida                      333-94265                          061562447
         -------                      ---------                          ---------
(State or other jurisdiction    (Commission File Number)   (IRS Employer Identification No.)
    of incorporation)
</TABLE>

                                 100 Main Street
                           Dover, New Hampshire 03820
               (Address of principal executive offices) (Zip Code)

                                 1-603 742-8100
          (Telephone number, including area code, of agent for service)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 23 0.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240. 14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240. 13e-4(c))

INFORMATION TO BE INCLUDED IN THE REPORT

LISKA BIOMETRY, INC. is referred to hereafter as "the Company," "we," or "our."
<PAGE>

--------------------------------------------------------------------------------
Item 1.01 Entry Into Material Definitive Agreement
Entry into Material Agreement, Financial Obligation Matter


Item 1.01. Entry into a Material Definitive Agreement.

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible Notes").  Pursuant to Section 2.2 of the Purchase Agreement,  Liska
is required  to place  $2,000,000  in the Escrow  Account,  and,  subject to the
provisions  of the  Purchase  Agreement  and  any of the  Transaction  Documents
regarding  release and use of such proceeds,  maintain such amount in the Escrow
Account for as long as CAMOFI shall have any obligations  outstanding  under the
Note. The Convertible  Notes will each mature on May 31st, 2009. The Convertible
Notes  bear an  interest  rate of 10%  per  annum.  The  Convertible  Notes  are
convertible  into shares of Liska  common stock at $0.40 per share and $0.60 per
share  respectively.  Liska  granted to CAMOFI  Master  LDC a priority  security
interest in our assets.

In addition to the Convertible Notes and pursuant to the financing  arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000  shares of
our common stock  ("Warrant").  The Warrant has a five year term and an exercise
price of $0.40 per share.

The Company has agreed to use its best  efforts to register the shares of common
stock underlying the Convertible Notes and the Warrant.

The  information in this Form 8-K and the attached  Exhibits is being  furnished
pursuant to Item 1.01 "Entry into a Material Definitive  Agreement" shall not be
deemed to be "filed" for purposes of Section 18 of the  Securities  Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise  subject to the liability
of  that  section,   and  shall  not  be  incorporated  by  reference  into  any
registration statement or other document filed under the Securities Act of 1933,
as amended,  or the  Exchange  Act,  except as shall be  expressly  set forth by
specific reference in such filing.

Item 2.03. Creation of Direct Financial Obligation.

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible  Notes"). The Convertible Notes will each mature on May 31st, 2009.
The  Convertible  Notes bear an interest rate of 10% per annum.  The Convertible
Notes are  convertible  into shares of Liska common stock at $0.40 per share and
$0.60 per share  respectively.  Liska  granted  to CAMOFI  Master LDC a priority
security interest in our assets.

In addition to the Convertible Notes and pursuant to the financing  arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000  shares of
our common stock  ("Warrant").  The Warrant has a five year term and an exercise
price of $0.40 per share.

The Company has agreed to use its best  efforts to register the shares of common
stock underlying the Convertible Notes and the Warrant.

The  information  in this Form 8-K and the attached  Exhibit is being  furnished
pursuant to Item 1.01 "Entry into a Material Definitive  Agreement" shall not be
deemed to be "filed" for purposes of Section 18 of the  Securities  Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise  subject to the liability
of  that  section,   and  shall  not  be  incorporated  by  reference  into  any
registration statement or other document filed under the Securities Act of 1933,
as amended,  or the  Exchange  Act,  except as shall be  expressly  set forth by
specific reference in such filing.
<PAGE>

Item 3.02 Unregistered Sales of Equity Securities

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible  Notes"). The Convertible Notes will each mature on May 31st, 2009.
The  Convertible  Notes bear an interest rate of 10% per annum.  The Convertible
Notes are  convertible  into shares of Liska common stock at $0.40 per share and
$0.60 per share  respectively.  Liska  granted  to CAMOFI  Master LDC a priority
security interest in our assets.

In addition to the Convertible Notes and pursuant to the financing arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000 shares of
our common stock ("Warrant"). The Warrant has a five year term and an exercise
price of $0.40 per share.

The Convertible Notes and Warrant were issued as restricted securities and are
exempt from registration under ss.5 of the Securities Act of 1933, as the
issuances are deemed exempt from registration under ss.3(a)(9), ss.4(1) and 4(2)
of the Securities Act of 1933

Item 7.01 Regulation FD Disclosure.

The information set forth under this Item 7.01,  including Exhibit 99.1 attached
hereto,  shall not be deemed  "filed"  for the  purposes  of  Section  18 of the
Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated
by  reference  in any  filing  under  the  Securities  Act,  except  as shall be
expressly set forth by specific reference in any such filing. Attached hereto as
Exhibit  99.1  is a Press  Release  issued  by the  Registrant  on June 9,  2006
regarding the consummation and effectiveness of the Agreement.

<PAGE>

Item 9.01         Financial Statements and Exhibits.

(c) Exhibits

                Exhibit
                Number       Description
                ------       -----------

                10.1         Securities Purchase Agreement

                10.2         Secured Promissory Note

                10.3         Secured Promissory Note

                10.4         Security Agreement

                10.5         Warrant Agreement

                99.1         Press Release dated June 9, 2006

<PAGE>

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                        Liska Biometry, Inc.
Dated: June 9, 2006

                                        By: /s/ Christopher LeClerc
                                            -------------------------------
                                            Christopher LeClerc, President and
                                            CFO
<PAGE>

                                INDEX TO EXHIBITS

                Exhibit
                Number       Description
                ------       -----------

                10.1         Securities Purchase Agreement

                10.2         Secured Promissory Note

                10.3         Secured Promissory Note

                10.4         Security Agreement

                10.5         Warrant Agreement

                99.1         Press Release dated June 9, 2006
{"company-data": {"conformed-name": "LISKA BIOMETRY INC", "cik": "0001102065", "assigned-sic": "9995", "irs-number": "061562447", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-94265", "film-number": "06897692"}, "business-address": {"street1": "6066 VINEYARD DRIVE", "city": "OTTAWA", "state": "A6", "zip": "K1C 2M5", "phone": "613-837-1909"}, "mail-address": {"street1": "6066 VINEYARD DRIVE", "city": "OTTAWA", "state": "A6", "zip": "K1C 2M5"}, "former-company": [{"former-conformed-name": "FTLA INC", "date-changed": "20020220"}, {"former-conformed-name": "FLORAN INTERNATIONAL INC", "date-changed": "20010403"}, {"former-conformed-name": "3045 CORP", "date-changed": "19991229"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                          Date of Report: June 6, 2006

                              Liska Biometry, Inc.
             (Exact name of registrant as specified in its chapter)
Florida                      333-94265                          061562447
         -------                      ---------                          ---------
(State or other jurisdiction    (Commission File Number)   (IRS Employer Identification No.)
    of incorporation)
100 Main Street
                           Dover, New Hampshire 03820
               (Address of principal executive offices) (Zip Code)

                                 1-603 742-8100
          (Telephone number, including area code, of agent for service)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 23 0.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240. 14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240. 13e-4(c))

INFORMATION TO BE INCLUDED IN THE REPORT

LISKA BIOMETRY, INC. is referred to hereafter as "the Company," "we," or "our."
--------------------------------------------------------------------------------
Item 1.01 Entry Into Material Definitive Agreement
Entry into Material Agreement, Financial Obligation Matter

Item 1.01. Entry into a Material Definitive Agreement.

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible Notes").  Pursuant to Section 2.2 of the Purchase Agreement,  Liska
is required  to place  $2,000,000  in the Escrow  Account,  and,  subject to the
provisions  of the  Purchase  Agreement  and  any of the  Transaction  Documents
regarding  release and use of such proceeds,  maintain such amount in the Escrow
Account for as long as CAMOFI shall have any obligations  outstanding  under the
Note. The Convertible  Notes will each mature on May 31st, 2009. The Convertible
Notes  bear an  interest  rate of 10%  per  annum.  The  Convertible  Notes  are
convertible  into shares of Liska  common stock at $0.40 per share and $0.60 per
share  respectively.  Liska  granted to CAMOFI  Master  LDC a priority  security
interest in our assets.

In addition to the Convertible Notes and pursuant to the financing  arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000  shares of
our common stock  ("Warrant").  The Warrant has a five year term and an exercise
price of $0.40 per share.

The Company has agreed to use its best  efforts to register the shares of common
stock underlying the Convertible Notes and the Warrant.

The  information in this Form 8-K and the attached  Exhibits is being  furnished
pursuant to Item 1.01 "Entry into a Material Definitive  Agreement" shall not be
deemed to be "filed" for purposes of Section 18 of the  Securities  Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise  subject to the liability
of  that  section,   and  shall  not  be  incorporated  by  reference  into  any
registration statement or other document filed under the Securities Act of 1933,
as amended,  or the  Exchange  Act,  except as shall be  expressly  set forth by
specific reference in such filing.

Item 2.03. Creation of Direct Financial Obligation.

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible  Notes"). The Convertible Notes will each mature on May 31st, 2009.
The  Convertible  Notes bear an interest rate of 10% per annum.  The Convertible
Notes are  convertible  into shares of Liska common stock at $0.40 per share and
$0.60 per share  respectively.  Liska  granted  to CAMOFI  Master LDC a priority
security interest in our assets.

In addition to the Convertible Notes and pursuant to the financing  arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000  shares of
our common stock  ("Warrant").  The Warrant has a five year term and an exercise
price of $0.40 per share.

The Company has agreed to use its best  efforts to register the shares of common
stock underlying the Convertible Notes and the Warrant.

The  information  in this Form 8-K and the attached  Exhibit is being  furnished
pursuant to Item 1.01 "Entry into a Material Definitive  Agreement" shall not be
deemed to be "filed" for purposes of Section 18 of the  Securities  Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise  subject to the liability
of  that  section,   and  shall  not  be  incorporated  by  reference  into  any
registration statement or other document filed under the Securities Act of 1933,
as amended,  or the  Exchange  Act,  except as shall be  expressly  set forth by
specific reference in such filing.
Item 3.02 Unregistered Sales of Equity Securities

On  June 5,  2006,  Liska  Biometry  Inc.  ("Liska")  entered  into a  financing
arrangement with CAMOFI Master LDC, an affiliate of Centrecourt Asset Management
LLC.  Under the  arrangement,  Liska issued  CAMOFI  Master LDC two  convertible
promissory  notes, one for $3,000,000 and a second for $2,000,000  (collectively
"Convertible  Notes"). The Convertible Notes will each mature on May 31st, 2009.
The  Convertible  Notes bear an interest rate of 10% per annum.  The Convertible
Notes are  convertible  into shares of Liska common stock at $0.40 per share and
$0.60 per share  respectively.  Liska  granted  to CAMOFI  Master LDC a priority
security interest in our assets.

In addition to the Convertible Notes and pursuant to the financing arrangement,
Liska issued CAMOFI Master LDC a warrant to purchase up to 12,500,000 shares of
our common stock ("Warrant"). The Warrant has a five year term and an exercise
price of $0.40 per share.

The Convertible Notes and Warrant were issued as restricted securities and are
exempt from registration under ss.5 of the Securities Act of 1933, as the
issuances are deemed exempt from registration under ss.3(a)(9), ss.4(1) and 4(2)
of the Securities Act of 1933

Item 7.01 Regulation FD Disclosure.

The information set forth under this Item 7.01,  including Exhibit 99.1 attached
hereto,  shall not be deemed  "filed"  for the  purposes  of  Section  18 of the
Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated
by  reference  in any  filing  under  the  Securities  Act,  except  as shall be
expressly set forth by specific reference in any such filing. Attached hereto as
Exhibit  99.1  is a Press  Release  issued  by the  Registrant  on June 9,  2006
regarding the consummation and effectiveness of the Agreement.
Item 9.01         Financial Statements and Exhibits.

(c) Exhibits

                Exhibit
                Number       Description
                ------       -----------

                10.1         Securities Purchase Agreement

                10.2         Secured Promissory Note

                10.3         Secured Promissory Note

                10.4         Security Agreement

                10.5         Warrant Agreement

                99.1         Press Release dated June 9, 2006
SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                        Liska Biometry, Inc.
Dated: June 9, 2006

                                        By: /s/ Christopher LeClerc
                                            -------------------------------
                                            Christopher LeClerc, President and
                                            CFO
INDEX TO EXHIBITS

                Exhibit
                Number       Description
                ------       -----------

                10.1         Securities Purchase Agreement

                10.2         Secured Promissory Note

                10.3         Secured Promissory Note

                10.4         Security Agreement

                10.5         Warrant Agreement

                99.1         Press Release dated June 9, 2006